American Vanguard earnings release, August 11, 2026
American Vanguard Reports Second Quarter 2026 Results
First-Half Gross Profit Increased 3%, and EBITDA Increased 21% on Mostly Flat Sales
Reaffirm Full-Year Outlook; Adjusted EBITDA $44 million to $48 million on Sales of $530 million to
$550 million
Irvine, CA | August 10, 2026 — American Vanguard Corporation, a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamental management and commercial pest control, today reported financial results for the second quarter and six-months ended June 30, 2026.
Second Quarter 2026 Financial and Operational Highlights – versus Second
Quarter 2025
First Half 2026 Financial and Operational Highlights – versus First Half 2025
Dak Kaye, CEO of American Vanguard, stated “Results for the second quarter and the first half of this year demonstrate the steady progress we are making on lowering costs and inventories, as well as driving commercial improvement, in spite of ongoing and dynamic crosscurrents affecting our agricultural markets and customers around the world. Our collective efforts to manage working capital, factory efficiency and controllable expenses while investing in the future have set the foundation for the opportunities that we believe lie ahead of us. Importantly, we are beginning to outperform our competition in our most important market, the U.S., and
I’m excited about the opportunity to build on this going forward and spread this across the rest of our businesses.”
Mr. Kaye continued,
“In our efforts to reorganize, refocus and invigorate the commercial effort across the Company, we are making good progress so far. Distributors, retailers and growers remain conservative in their buying practices, ordering on an as needed basis and deferring purchases month to month where they can. This, in turn, has shifted order patterns across our businesses, both domestically and internationally. In this environment, we must be agile, and our focus and efforts right now¹ are to increase customer engagement and drive customer service while at the same time accelerating new product development and introduction, always striving to be a solutions provider for our customers, wherever we meet them. With the first half behind us and our cost and commercial initiatives executing to our plan, we are reaffirming our full-year outlook.”
David Johnson, Chief Financial Officer stated, “Second quarter gross margin reflected lower sales and the timing of customer shipments, but first half margin still improved 100 basis points on slightly lower sales, a direct result of our business improvement plan efforts. We reduced operating expenses by 3% year-over-year for the quarter, as we continued to drive efficiency across the organization, while continuing to invest for future growth including a 12% increase in R&D investment. Importantly, a number of actions taken in the first half of 2026, including the L.A. plant optimization and headquarter relocation will translate into lower costs in the second half of this year. As a reminder, we expect the rationalization of the L.A. production facility to save us at least $4 million on an annualized basis going forward. Inventories decreased by
$10 million year-over-year, reflecting tighter production planning and working capital discipline.”
Earnings Conference Call
The company will be hosting an earnings conference call on August 10, 2026 at 4:30 pm Eastern Time/1:30 pm Pacific Time.
The conference call will be webcast on the Company’s website at https://www.investors-american vanguard.com
/ or by going to the following link: https://www.webcaster5.com/Webcast/Page/3070/54326
If you are unable to listen live, the conference call will be archived for one year and may be accessed using the company’s website: https://www.investors-american-vanguard.com/
About American Vanguard
American Vanguard Corporation is a diversified specialty and agriculture products company that develops and markets products for crop protection and management, turf and ornamentals management, and public health. Over the past 20 years, through product and business acquisitions, the Company has significantly expanded its operations and now has more than 1,000 product registrations worldwide. To learn more about the Company, please reference www.american-vanguard.com.
The Company, from time to time, may discuss forward-looking information.
Financial statements
Income Statement
For the Three Months Ended June 30, — (Unaudited) (in thousands)
| For the Three Months Ended June 30, – 2026 | For the Three Months Ended June 30, – 2025 | For the Six Months Ended June 30, – 2026 | For the Six Months Ended June 30, – 2025 | ||
|---|---|---|---|---|---|
| Net sales | 116,754 | 129,313 | 240,322 | 245,113 | |
| Cost of sales | -82,041 | -88,766 | -167,192 | -174,375 | |
| Gross profit | 34,713 | 40,547 | 73,130 | 70,738 | |
| Operating expenses | Selling, general and administrative | -26,623 | -28,623 | -54,336 | -55,251 |
| Operating expenses | Research, product development and regulatory | -6,484 | -5,803 | -11,755 | -11,485 |
| Operating expenses | Product liability claims | -119 | -201 | ||
| Operating expenses | Transformation | -1,506 | -1,621 | -4,310 | -3,812 |
| Operating expenses | Asset impairments | -284 | -134 | -943 | -134 |
| Operating expenses | Operating (loss) income | -303 | 4,366 | 1,585 | 56 |
| Operating expenses | Change in fair value of an equity investment | -52 | -172 | ||
| Operating expenses | Interest expense, net | -9,130 | -4,450 | -14,920 | -8,215 |
| Operating expenses | Loss before provision for income taxes | -9,485 | -84 | -13,507 | -8,159 |
| Operating expenses | Income tax expense | -383 | -765 | -507 | -1,152 |
| Operating expenses | Net loss | -9,868 | -849 | -14,014 | -9,311 |
| Operating expenses | Net loss per common share—basic | -0.34 | -0.03 | -0.49 | -0.33 |
| Operating expenses | Net loss per common share—assuming dilution | -0.34 | -0.03 | -0.49 | -0.33 |
| Operating expenses | Weighted average shares outstanding—basic | 28,649 | 28,345 | 28,649 | 28,308 |
| Operating expenses | Weighted average shares outstanding—assuming dilution | 28,649 | 28,345 | 28,649 | 28,308 |
Income Statement
For the Three Months Ended June 30, — (Unaudited) (in thousands)
| For the Three Months Ended June 30, – 2026 | For the Three Months Ended June 30, – 2025 | Change | % Change | ||
|---|---|---|---|---|---|
| Net sales: | U.S. crop | 48,033 | 52,674 | -4,641 | -9.0% |
| Net sales: | U.S. Specialty | 21,804 | 19,585 | 2,219 | 11.0% |
| Net sales: | Total U.S. | 69,837 | 72,259 | -2,422 | -3.0% |
| Net sales: | International | 46,917 | 57,054 | -10,137 | -18.0% |
| Net sales: | Total net sales | 116,754 | 129,313 | -12,559 | -10.0% |
| Net sales: | Total cost of sales | -82,041 | -88,766 | 6,725 | -8.0% |
| Net sales: | Total gross profit | 34,713 | 40,547 | -5,834 | -14.0% |
| Net sales: | Total gross margin | 30.0% | 31 |
Income Statement
For the Six Months Ended June 30, — (Unaudited) (in thousands)
| For the Six Months Ended June 30, – 2026 | For the Six Months Ended June 30, – 2025 | Change | % Change | ||
|---|---|---|---|---|---|
| Net sales: | U.S. crop | 115,193 | 110,201 | 4,992 | 5.0% |
| Net sales: | U.S. Specialty | 38,174 | 34,834 | 3,340 | 10.0% |
| Net sales: | Total U.S. | 153,367 | 145,035 | 8,332 | 6.0% |
| Net sales: | International | 86,955 | 100,078 | -13,123 | -13.0% |
| Net sales: | Total net sales | 240,322 | 245,113 | -4,791 | -2.0% |
| Net sales: | Total cost of sales | -167,192 | -174,375 | 7,183 | -4.0% |
| Net sales: | Total gross profit | 73,130 | 70,738 | 2,392 | 3.0% |
| Net sales: | Total gross margin | 30.0% | 29 |
Income Statement
For the Three Months Ended June 30, — (Unaudited) (in thousands)
| For the Three Months Ended June 30, – 2026 | For the Three Months Ended June 30, – 2025 | For the Six Months Ended June 30, – 2026 | For the Six Months Ended June 30, – 2025 | |
|---|---|---|---|---|
| Net loss | -9,868 | -849 | -14,014 | -9,311 |
| Provision for income taxes | 383 | 765 | 507 | 1,152 |
| Interest expense, net | 9,130 | 4,450 | 14,920 | 8,215 |
| Depreciation and amortization | 4,618 | 4,709 | 9,241 | 9,458 |
| Stock compensation expense | 388 | 422 | 574 | 981 |
| Transformation costs | 1,506 | 1,621 | 4,310 | 3,812 |
| Asset impairments | 284 | 134 | 943 | 134 |
| Other | 173 | -213 | 392 | -429 |
| Adjusted EBITDA(1) | 6,614 | 11,039 | 16,873 | 14,012 |
Balance Sheet
June 30, 2026 — (In thousands, except share data) (Unaudited)
| June 30, 2026 | December 31, 2025 | ||
|---|---|---|---|
| Current assets: | Cash | 43,901 | 12,425 |
| Receivables: | Trade, net of allowance for credit losses of $13,219 and $11,733, respectively | 174,608 | 160,511 |
| Receivables: | Other | 8,852 | 7,278 |
| Receivables: | Total receivables, net | 183,460 | 167,789 |
| Receivables: | Inventories | 181,382 | 176,034 |
| Receivables: | Prepaid expenses | 7,388 | 9,668 |
| Receivables: | Income taxes receivable | 1,620 | 4,606 |
| Receivables: | Total current assets | 417,751 | 370,522 |
| Receivables: | Property, plant and equipment, net | 51,178 | 53,036 |
| Receivables: | Operating lease right-of-use assets, net | 16,052 | 16,793 |
| Receivables: | Intangible assets, net | 133,185 | 138,746 |
| Receivables: | Deferred income tax assets | 3,020 | 2,637 |
| Receivables: | Other assets | 14,157 | 14,803 |
| Receivables: | Total assets | 635,343 | 596,537 |
| Current liabilities: | Current portion of long-term debt | 2,250 | $— |
| Current liabilities: | Accounts payable | 87,295 | 87,505 |
| Current liabilities: | Customer prepayments | 741 | 33,094 |
| Current liabilities: | Accrued program costs | 48,306 | 52,227 |
| Current liabilities: | Accrued expenses and other payables | 22,800 | 28,261 |
| Current liabilities: | Operating lease liabilities, current | 5,289 | 5,765 |
| Current liabilities: | Income taxes payable | 2,115 | 2,594 |
| Current liabilities: | Total current liabilities | 168,796 | 209,446 |
| Current liabilities: | Long-term debt, net of current portion | 265,369 | 174,000 |
| Current liabilities: | Operating lease liabilities, long-term | 11,216 | 11,621 |
| Current liabilities: | Deferred income tax liabilities | 7,675 | 8,150 |
| Current liabilities: | Other liabilities | 900 | 923 |
| Current liabilities: | Total liabilities | 453,956 | 404,140 |
| Stockholders’ equity: | Common stock, $0.10 par value per share; authorized 40,000,000 shares; issued 34,850,939 shares at June 30, 2026 and 34,923,562 shares at December 31, 2025 | 3,485 | 3,492 |
| Stockholders’ equity: | Additional paid-in capital | 117,855 | 117,106 |
| Stockholders’ equity: | Accumulated other comprehensive loss | -9,739 | -12,000 |
Cash Flow
For the Six Months Ended June 30, — (Unaudited) (in thousands)
| For the Six Months Ended June 30, – 2026 | For the Six Months Ended June 30, – 2025 | ||
|---|---|---|---|
| Cash flows from operating activities: | Net loss | -14,014 | -9,311 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Depreciation and amortization of property, plant and equipment and intangible assets | 9,026 | 9,447 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Amortization of other long-term assets | 11 | |
| Adjustments to reconcile net loss to net cash used in operating activities: | Loss (gain) on disposal of property, plant and equipment | 55 | -40 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Provision for estimated credit losses | 1,327 | 1,999 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Stock-based compensation | 574 | 981 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Deferred income taxes | -690 | -200 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Change in liabilities for uncertain tax positions or unrecognized tax benefits | -50 | -60 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Change in equity investment fair value | 172 | |
| Adjustments to reconcile net loss to net cash used in operating activities: | Impairment of assets | 943 | 134 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Payment-in-kind debt leverage fee | 676 | |
| Adjustments to reconcile net loss to net cash used in operating activities: | Amortization of deferred loan fees | 1,786 | 569 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Lease obligations and non-cash lease expense, net | -140 | -100 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Unrealized foreign currency transaction losses (gains) | 603 | -855 |
| Changes in assets and liabilities associated with operations: | Increase in net receivables | -16,225 | -3,293 |
| Changes in assets and liabilities associated with operations: | Increase in inventories | -4,280 | -9,785 |
| Changes in assets and liabilities associated with operations: | Increase in prepaid expenses and other assets | -339 | -1,863 |
| Changes in assets and liabilities associated with operations: | Change in income tax receivable and payable, net | 2,506 | -1,024 |
| Changes in assets and liabilities associated with operations: | (Decrease) increase in accounts payable | -459 | 24,547 |
| Changes in assets and liabilities associated with operations: | Decrease in customer prepayments | -32,353 | -46,187 |
| Changes in assets and liabilities associated with operations: | (Decrease) increase in accrued program costs | -3,967 | 10,267 |
| Changes in assets and liabilities associated with operations: | Decrease in other payables and accrued expenses | -5,611 | -15,073 |
| Changes in assets and liabilities associated with operations: | Net cash used in operating activities | -60,460 | -39,836 |
| Cash flows from investing activities: | Capital expenditures | -2,322 | -1,020 |
| Cash flows from investing activities: | Proceeds from disposal of property, plant and equipment | 12 | 51 |
| Cash flows from investing activities: | Intangible assets | -109 | -88 |
| Cash flows from investing activities: | Net cash used in investing activities | -2,419 | -1,057 |
| Cash flows from financing activities: | Payments under line of credit agreement | -140,000 | -128,665 |
| Cash flows from financing activities: | Borrowings under line of credit agreement | 26,000 | 170,834 |
| Cash flows from financing activities: | Borrowings under term loans | 225,000 | |
| Cash flows from financing activities: | Repayments of term loans | -563 | |
| Cash flows from financing activities: | Payment of deferred loan fees | -16,234 | -881 |
| Cash flows from financing activities: | Net receipt from the issuance of common stock under ESPP | 263 | 333 |
| Cash flows from financing activities: | Net payment from common stock purchased for tax withholding | -95 | -142 |
| Cash flows from financing activities: | Net cash provided by financing activities | 94,371 | 41,479 |
| Cash flows from financing activities: | Net increase in cash | 31,492 | 586 |
| Cash flows from financing activities: | Effect of exchange rate changes on cash and cash equivalents | -16 | 1,382 |
| Cash flows from financing activities: | Cash at beginning of period | 12,425 | 12,514 |
| Cash flows from financing activities: | Cash at end of period | 43,901 | 14,482 |
Full release
Except for the historical information contained in this release the matters set forth in this press release include forward-looking statements. These statements can be identified by the fact that they do not relate strictly to historical or current facts. Forward looking statements often use words such as “believe,” “expect,” “anticipate,” “intend,” “estimate,” “project,” “outlook,” “forecast,”
“target,” “trend,” “plan,” “goal,” or other words of comparable meaning or future-tense or conditional verbs such as “may,” “will,” “should,” “would,” or
“could.” These forward-looking statements are based on the current expectations and estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include risks detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release. The company disclaims any intent or obligation to update these forward-looking statements.²
Non-GAAP
Financial Measures
In addition to providing results that are determined in accordance with accounting principles generally accepted in the United States of America (GAAP), we present Adjusted EBITDA and Net Debt, which are non-GAAP... (truncated)e considered in isolation or as an alternative to GAAP measures such as net income, or diluted earnings per share, as applicable, or other financial statement data presented in our financial statements as an indicator of our financial performance or liquidity.
We define Net Debt as outstanding indebtedness less cash and EBITDA as net (loss) income, adjusted for depreciation and amortization, provision for income taxes and interest expense. We define Adjusted EBITDA as EBITDA as further adjusted for stock compensation expense and for certain items management believe are not reflective of the underlying operations of our business, including but not limited to the exclusion of charges that are considered by management to be unusual and not representative of the Company’s underlying performance and future prospects. In 2026 and 2025 that included non-recurring expenses. The resulting Adjusted EBITDA measure is aligned with the Company’s metric for its credit facility agreement in the applicable periods.
We use Adjusted EBITDA to assess the operating results and effectiveness and efficiency of our business. We present this non-GAAP financial measure because we believe that investors consider Adjusted EBITDA to be an important supplemental measure of performance, and we believe that this measure is frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry. As the Company continues to work through its transformation efforts, management believes that presenting Adjusted EBITDA provides an effective comparison between the Company and its industry peers.
Non-GAAP financial measures as reported by us may not be comparable to similarly titled metrics reported by other companies and may not be calculated in the same manner. These measures have limitations as analytical tools, and you should not consider them in isolation or as substitutes for analysis of our results as reported under GAAP.
The Company is not able to provide a reconciliation without unreasonable efforts of its forward-looking guidance related to adjusted EBITDA to the most directly comparable GAAP financial measure due to the inherent difficulty in predicting with reasonable certainty the timing and amount of certain items that are excluded from Adjusted EBITDA, such as share-based compensation, acquisition-related expenses, and foreign exchange gains or losses, which could be material to the Company’s results computed in accordance with GAAP.
Investor
Representative
Alpha IR Group
Robert Winters
Robert.winters@alpha-ir.com
(917)
821-6305